Integrin cross-talk regulates the human neutrophil response to fungal β-glucan in the context of the extracellular matrix: A prominent role for VLA3 in the antifungal response

Journal of Immunology

Volumn 198, Issue 1, 2017, Pages 318-334

  Johnson, Courtney M ^a,b,c   O'Brien, Xian M ^a,b   Byrd, Angel S ^a,b,c   Parisi, Valentina E ^a,c   Loosely, Alex J ^c   Li, Wei ^a   Witt, Hadley ^a,b,c   Faridi, Hafeez M ^d   Lefort, Craig T ^a,b   Gupta, Vineet ^d   Kim, Minsoo ^e   Reichner, Jonathan S ^a,b,c  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; FIBRONECTIN; INTEGRIN; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5; FUNGAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CANDIDA ALBICANS; CELL ADHESION; COMPLEMENT ACTIVATION; CONFORMATIONAL TRANSITION; DOWN REGULATION; EXTRACELLULAR MATRIX; FUNGUS HYPHAE; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; LEUKOCYTE AGGREGATION; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION; CELL SEPARATION; EXTRACELLULAR TRAP; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOLOGY; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION;

BETA-GLUCANS; CANDIDA ALBICANS; CELL SEPARATION; EXTRACELLULAR MATRIX; EXTRACELLULAR TRAPS; FLUORESCENCE RESONANCE ENERGY TRANSFER; FUNGAL PROTEINS; HUMANS; INTEGRIN ALPHA3BETA1; MACROPHAGE-1 ANTIGEN; MICROSCOPY, ELECTRON, SCANNING; NEUTROPHILS; RECEPTOR CROSS-TALK;

EID: 85006984142     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502381     Document Type: Article

References (46)

1. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309-317.
2. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34: 909-917.
3. Horn, D. L., D. Neofytos, E. J. Anaissie, J. A. Fishman, W. J. Steinbach, A. J. Olyaei, K. A. Marr, M. A. Pfaller, C. H. Chang, and K. M. Webster. 2009. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48: 1695-1703.
4. Zaoutis, T. E., J. Argon, J. Chu, J. A. Berlin, T. J. Walsh, and C. Feudtner. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41: 1232-1239.
5. Miller, L. G., R. A. Hajjeh, and J. E. Edwards, Jr. 2001. Estimating the cost of nosocomial candidemia in the United States. Clin. Infect. Dis. 32: 1110.
6. Wilson, L. S., C. M. Reyes, M. Stolpman, J. Speckman, K. Allen, and J. Beney. 2002. The direct cost and incidence of systemic fungal infections. Value Health 5: 26-34.
7. Edmond, M. B., S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R. P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29: 239-244.
8. Blumberg, H. M., W. R. Jarvis, J. M. Soucie, J. E. Edwards, J. E. Patterson, M. A. Pfaller, M. S. Rangel-Frausto, M. G. Rinaldi, L. Saiman, R. T. Wiblin, and R. P. Wenzel, National Epidemiology of Mycoses Survey (NEMIS) Study Group, The National Epidemiology of Mycosis Survey. 2001. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin. Infect. Dis. 33: 177-186.
9. León, C., S. Ruiz-Santana, P. Saavedra, B. Almirante, J. Nolla-Salas, F. Alvarez-Lerma, J. Garnacho-Montero, and M. A. León, EPCAN Study Group. 2006. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit. Care Med. 34: 730-737.
10. Manolakaki, D., G. Velmahos, T. Kourkoumpetis, Y. Chang, H. B. Alam, M. M. De Moya, and E. Mylonakis. 2010. Candida infection and colonization among trauma patients. Virulence 1: 367-375.
11. Kourkoumpetis, T., D. Manolakaki, G. Velmahos, Y. Chang, H. B. Alam, M. M. De Moya, E. A. Sailhamer, and E. Mylonakis. 2010. Candida infection and colonization among non-trauma emergency surgery patients. Virulence 1: 359-366.
12. Pfaller, M. A. 1999. Molecular epidemiology in the care of patients. Arch. Pathol. Lab. Med. 123: 1007-1010.
13. Engelhardt, K. R., and B. Grimbacher. 2012. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J. Allergy Clin. Immunol. 129: 294-305, quiz 306-307.
14. Puel, A., S. Cypowyj, J. Bustamante, J. F. Wright, L. Liu, H. K. Lim, M. Migaud, L. Israel, M. Chrabieh, M. Audry, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332: 65-68.
15. Van't Wout, J. W., J. W. Van der Meer, M. Barza, and C. A. Dinarello. 1988. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. Eur. J. Immunol. 18: 1143-1146.
16. van den Berg, J. M., E. van Koppen, A. Ahlin, B. H. Belohradsky, E. Bernatowska, L. Corbeel, T. Español, A. Fischer, M. Kurenko-Deptuch, R. Mouy, et al. 2009. Chronic granulomatous disease: the European experience. PLoS One 4: e5234.
17. Cheng, S. C., L. A. Joosten, B. J. Kullberg, and M. G. Netea. 2012. Interplay between Candida albicans and the mammalian innate host defense. Infect. Immun. 80: 1304-1313.
18. Branzk, N., A. Lubojemska, S. E. Hardison, Q. Wang, M. G. Gutierrez, G. D. Brown, and V. Papayannopoulos. 2014. Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat. Immunol. 15: 1017-1025.
19. Byrd, A. S., X. M. O'Brien, C. M. Johnson, L. M. Lavigne, and J. S. Reichner. 2013. An extracellular matrix-based mechanism of rapid neutrophil extracellular trap formation in response to Candida albicans. J. Immunol. 190: 4136-4148.
20. Xia, Y., and G. D. Ross. 1999. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18). J. Immunol. 162: 7285-7293.
21. Forsyth, C. B., E. F. Plow, and L. Zhang. 1998. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J. Immunol. 161: 6198-6205.
22. Diamond, M. S., J. Garcia-Aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120: 1031-1043.
23. Thornton, B. P., V. Vetvicka, M. Pitman, R. C. Goldman, and G. D. Ross. 1996. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156: 1235-1246.
24. Bose, N., A. S. Chan, F. Guerrero, C. M. Maristany, X. Qiu, R. M. Walsh, K. E. Ertelt, A. B. Jonas, K. B. Gorden, C. M. Dudney, et al. 2013. Binding of soluble yeast β-glucan to human neutrophils and monocytes is complement-dependent. Front. Immunol. 4: 230.
25. Lefort, C. T., Y. M. Hyun, J. B. Schultz, F. Y. Law, R. E. Waugh, P. A. Knauf, and M. Kim. 2009. Outside-in signal transmission by conformational changes in integrin Mac-1. J. Immunol. 183: 6460-6468.
26. O'Brien, X. M., K. E. Heflin, L. M. Lavigne, K. Yu, M. Kim, A. R. Salomon, and J. S. Reichner. 2012. Lectin site ligation of CR3 induces conformational changes and signaling. J. Biol. Chem. 287: 3337-3348.
27. Welzenbach, K., U. Hommel, and G. Weitz-Schmidt. 2002. Small molecule inhibitors induce conformational changes in the I domain and the I-like domain of lymphocyte function-associated antigen-1. Molecular insights into integrin inhibition. J. Biol. Chem. 277: 10590-10598.
28. Yang, W., C. V. Carman, M. Kim, A. Salas, M. Shimaoka, and T. A. Springer. 2006. A small molecule agonist of an integrin, alphaLbeta2. J. Biol. Chem. 281: 37904-37912.
29. Maiguel, D., M. H. Faridi, C. Wei, Y. Kuwano, K. M. Balla, D. Hernandez, C. J. Barth, G. Lugo, M. Donnelly, A. Nayer, et al. 2011. Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci. Signal. 4: ra57.
30. Hyun, Y. M., R. Sumagin, P. P. Sarangi, E. Lomakina, M. G. Overstreet, C. M. Baker, D. J. Fowell, R. E. Waugh, I. H. Sarelius, and M. Kim. 2012. Uropod elongation is a common final step in leukocyte extravasation through inflamed vessels. J. Exp. Med. 209: 1349-1362.
31. Yao, N., W. Xiao, X. Wang, J. Marik, S. H. Park, Y. Takada, and K. S. Lam. 2009. Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J. Med. Chem. 52: 126-133.
32. Pattaramalai, S., K. M. Skubitz, and A. P. Skubitz. 1996. A novel recognition site on laminin for the α 3 β 1 integrin. Exp. Cell Res. 222: 281-290.
33. Clark, K., R. Pankov, M. A. Travis, J. A. Askari, A. P. Mould, S. E. Craig, P. Newham, K. M. Yamada, and M. J. Humphries. 2005. A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J. Cell Sci. 118: 291-300.
34. Pfaller, M. A., L. Boyken, R. J. Hollis, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2005. In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole. J. Clin. Microbiol. 43: 5425-5427.
35. Tavanti, A., A. D. Davidson, M. J. Fordyce, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Population structure and properties of Candida albicans, as determined by multilocus sequence typing. J. Clin. Microbiol. 43: 5601-5613.
36. Blystone, S. D., I. L. Graham, F. P. Lindberg, and E. J. Brown. 1994. Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. J. Cell Biol. 127: 1129-1137.
37. Gonzalez, A. M., R. Bhattacharya, G. W. deHart, and J. C. R. Jones. 2010. Transdominant regulation of integrin function: mechanisms of cross-talk. Cell. Signal. 22: 578-583.
38. Porter, J. C., and N. Hogg. 1997. Integrin cross-talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function. J. Cell Biol. 138: 1437-1447.
39. Urban, C. F., U. Reichard, V. Brinkmann, and A. Zychlinsky. 2006. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell. Microbiol. 8: 668-676.
40. Diamond, R. D., R. Krzesicki, B. Epstein, and W. Jao. 1978. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am. J. Pathol. 91: 313-328.
41. Harler, M. B., E. Wakshull, E. J. Filardo, J. E. Albina, and J. S. Reichner. 1999. Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins. J. Immunol. 162: 6792-6799.
42. Lerman, Y. V., K. Lim, Y. M. Hyun, K. L. Falkner, H. Yang, A. P. Pietropaoli, A. Sonnenberg, P. P. Sarangi, and M. Kim. 2014. Sepsis lethality through exacerbated tissue infiltration and TLR-induced cytokine production by neutrophils is dependent on integrin alpha3beta1. Blood 124: 3515-3523.
43. Yipp, B. G., B. Petri, D. Salina, C. N. Jenne, B. N. Scott, L. D. Zbytnuik, K. Pittman, M. Asaduzzaman, K. Wu, H. C. Meijndert, et al. 2012. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18: 1386-1393.
44. Johansson, S., G. Svineng, K. Wennerberg, A. Armulik, and L. Lohikangas. 1997. Fibronectin-integrin interactions. Front. Biosci. 2: d126-d146.
45. Nagae, M., S. Re, E. Mihara, T. Nogi, Y. Sugita, and J. Takagi. 2012. Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor. J. Cell Biol. 197: 131-140.
46. Lavigne, L. M., X. M. O'Brien, M. Kim, J. W. Janowski, J. E. Albina, and J. S. Reichner. 2007. Integrin engagement mediates the human polymorphonuclear leukocyte response to a fungal pathogen-associated molecular pattern. J. Immunol. 178: 7276-7282.